Feasibility of a comprehensive monitoring protocol for the prevention and treatment of interstitial lung disease in patients undergoing treatment with fam-trastuzumab deruxtecan
Conferences
Moore, H; Shofer, S; Guisinger, A; Broadwater, G; Force, J; Sammons, S; Anders, C; Westbrook, K
Published in: CANCER RESEARCH
February 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
CANCER RESEARCH
EISSN
1538-7445
ISSN
0008-5472
Publication Date
February 2021
Volume
81
Issue
4
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Moore, H., Shofer, S., Guisinger, A., Broadwater, G., Force, J., Sammons, S., … Westbrook, K. (2021). Feasibility of a comprehensive monitoring protocol for the prevention and treatment of interstitial lung disease in patients undergoing treatment with fam-trastuzumab deruxtecan. In CANCER RESEARCH (Vol. 81).
Moore, Heather, Scott Shofer, Amy Guisinger, Gloria Broadwater, Jeremy Force, Sarah Sammons, Carey Anders, and Kelly Westbrook. “Feasibility of a comprehensive monitoring protocol for the prevention and treatment of interstitial lung disease in patients undergoing treatment with fam-trastuzumab deruxtecan.” In CANCER RESEARCH, Vol. 81, 2021.
Moore H, Shofer S, Guisinger A, Broadwater G, Force J, Sammons S, et al. Feasibility of a comprehensive monitoring protocol for the prevention and treatment of interstitial lung disease in patients undergoing treatment with fam-trastuzumab deruxtecan. In: CANCER RESEARCH. 2021.
Moore, Heather, et al. “Feasibility of a comprehensive monitoring protocol for the prevention and treatment of interstitial lung disease in patients undergoing treatment with fam-trastuzumab deruxtecan.” CANCER RESEARCH, vol. 81, no. 4, 2021.
Moore H, Shofer S, Guisinger A, Broadwater G, Force J, Sammons S, Anders C, Westbrook K. Feasibility of a comprehensive monitoring protocol for the prevention and treatment of interstitial lung disease in patients undergoing treatment with fam-trastuzumab deruxtecan. CANCER RESEARCH. 2021.
Published In
CANCER RESEARCH
EISSN
1538-7445
ISSN
0008-5472
Publication Date
February 2021
Volume
81
Issue
4
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology